Clinical Trial Update: Double-blind, Placebo-Controlled Divalproex Sodium ER in Bipolar I or Bipolar II Depression [Phase 3]

View source ↗

Summary

A Phase 3 double-blind, placebo-controlled trial of divalproex sodium extended-release for bipolar I or II depression has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Divalproex Sodium ER (divalproex sodium ER)

Snippet

Sponsor: University Hospitals Cleveland Medical Center | Conditions: Bipolar Disorder | Phase 3 | Status: COMPLETED | Results posted: 2019-07-17